GlassScriptPhysician profile
Nicole D Cresce
NPI 1629496518
$1,258.92
in general payments reported to CMS, 2019-2025
18 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $362 · 2021: $409 · 2022: $14.00 · 2024: $36.93 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $99.99 · Food and Beverage: $62.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $99.99 |
| Food and Beverage | $62.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $413.80 | 2019-2024 | |
| Janssen Biotech, INC. | $211.76 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $123.51 | 2020-2025 | |
| Vyne Pharmaceuticals INC. | $84.83 | 2021 | |
| Galderma Laboratories, L.P. | $79.92 | 2019-2025 | Nemluvio |
| Pfizer INC. | $63.34 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $57.43 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $41.57 | 2021 | |
| Ucb, INC. | $40.67 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $23.66 | 2024 | |
| Genentech USA, INC. | $17.74 | 2019 | |
| Mayne Pharma Commercial LLC | $16.24 | 2019 | |
| Medtronic Vascular, INC. | $15.36 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $15.27 | 2019 | |
| Mission Pharmacal Company | $15.00 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.03 | 2021 | |
| Dermavant Sciences, INC. | $14.00 | 2022 | |
| Organon LLC | $10.79 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Cresce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.